Plasma lipids and vascular dysfunction in preeclampsia

Seminars in Reproductive Endocrinology

Volumn 16, Issue 1, 1998, Pages 33-39

  Lorentzen, Bjørg ^a   Henriksen, Tore ^b,c  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Endothelial cells; Free fatty acids; Placenta; Plasma lipids; Preeclampsia

Indexed keywords

LIPID; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; UTERINE ARTERY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0031748307     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016250     Document Type: Review

References (66)

1. Redman CWG. Current topic: Pre-eclampsia and the placenta. Placenta 1991;12:301-308
2. Cockell AP, Learmont JG, Smárason AK, Redman CWG, Sargent IL, Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 1997;104:235-240
3. Walsh SW. Lipid peroxidation in pregnancy. Hypertens Pregnancy 1994;13:1-32
4. Maseki M, Nishigaki I, Hagihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without preeclampsia. Clin Chim Acta 1981;115:155-161
5. Torbergsen T, Øian P, Mathiesen E, Borud O. Pre-eclampsia - a mitochondrial disease? Acta Obstet Gynecol Scand 1989;68:145-148
6. Boyd EM. The lipidemia of pregnancy. J Clin Invest 1934; 13:347-363
7. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979;133:165-170
8. Darmady JM, Postle AD. Lipid metabolism in pregnancy. Br J Obstet Gynaecol 1982;89:211-215
9. Salameh WA, Mastrogiannis S. Maternal hyperlipidemia in pregnancy. Clin Obstet Gynecol 1994;37:66-77
10. Silliman K, Shore V, Forte TM. Hypertriglyceridemia during late pregnancy is associated with the formation of small dense low-density lipoproteins and the presence of large buoyant high-density lipoproteins. Metabolism 1994;43: 1035-1041
11. Burt RL. Plasma nonesterified fatty acids in normal pregnancy and the puerperium. Obstet Gynecol 1960;15:460-464
12. Satter N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br J Obstet Gynaecol 1996;103:614-620
13. Satter N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: Pathogenic parallels to atherosclerosis. Obstet Gynecol 1997;89:403-409
14. Lorentzen B, Endresen MJ, Hovik T, Haug E, Henriksen T. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb Res 1991;63:363-372
15. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996;174:975-982
16. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995;85:353-356
17. Lorentzen B, Drevon CA, Endresen MJ, Henriksen T. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and pre-eclamptic pregnancy. Br J Obstet Gynaecol 1995;102:530-537
18. Wang Y, Kay HH, Killam AP. Decreased levels of polyunsaturated fatty acids in preeclampsia. Am J Obstet Gynecol 1991;164:812-818
19. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, McLaughlin MK. Lipid peroxidation in pregnancy: New perspective on preeclampsia. Am J Obstet Gynecol 1989; 161:1025-1034
20. Lorentzen B, Endresen MJ, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 1994;13:103-109
21. Gratacós E, Casals E, Sanllehy C, Cararach V, Alonso PL, Fortuny A. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand 1996;75:896-901
22. Pijnenborg R. The placental bed. Hypertens Pregnancy 1996;15:7-23
23. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994;101:669-674
24. Zeek PM, Assali NS. Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy. Am J Clin Pathol 1950;20:1099-1109
25. Navab M, Berliner JA, Watson AD, et al. The yin and yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 1996;16:831-842
26. LaRosa JC. Cholesterol lowering, low cholesterol, and mortality. Am J Cardiol 1993;72:776-786
27. Woolf N. Pathology of atherosclerosis. Br Med Bull 1990; 46:960-985
28. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924
29. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptor for acetylated low density lipoproteins. Proc Natl Acad Sci USA 1980;77:2214-2218
30. Henriksen T, Mahoney EM, Steinberg D. Interactions of plasma lipoproteins with endothelial cells. Ann NY Acad Sci 1982;401:102-116
31. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vase Biol 1995; 15:551-561
32. Libby P, Geng YJ, Aikawa M, et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996;7:330-335
33. Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-234
34. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993;341:1496-1500
35. Harrington K, Cooper D, Lees C, Hecher K, Campbell S. Doppler ultrasound of the uterine arteries: The importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 1996;7:182-188
36. Murakoshi T, Sekizuka N, Takakuwa K, Yoshizawa H, Tanaka K. Uterine and spiral artery flow velocity waveforms in pregnancy-induced hypertension and/or intrauterine growth retardation. Ultrasound Obstet Gynecol 1996;7:122-128
37. Henry PD. Hyperlipidemic arterial dysfunction. Circulation 1990;81:697-699
38. Endresen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 1992;167:440-147
39. Endresen MJ, Tosti E, Heimli H, Lorentzen B, Henriksen T. Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand J Clin Lab Invest 1994;54:549-557
40. Baker PN, Davidge ST, Barankiewicz J, Roberts JM. Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension 1996;27:56-61
41. Toborek M, Barger SW, Mattson MP, Barve S, McClein CJ, Hennig B. Linoleic acid and TNF-α cross-amplify oxidative injury and dysfunction of endothelial cells. J Lipid Res 1996;37:123-135
42. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CWG. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br J Obstet Gynecol 1995;102:20-25
43. Steinberg HO, Tarshoby M, Monestel R, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997;100:1230-1239
44. Solomon CG, Graves SW, Greene MF, Seely EW. Glucose intolerance as a predictor of hypertension in pregnancy. Hypertension 1994;23:717-721
45. Lorentzen B, Birkeland KI, Endresen MJ, Henriksen T. Glucose intolerance in women with preeclampsia. Acta Obstet Gynecol Scand 1998;77:22-27
46. McNamara JR, Jenner JL, Zengling L, Wilson PNF, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992;12:1284-1290
47. Chapman MJ, Bruckert E. The atherogenic role of triglycerides and small, dense low density lipoproteins: Impact of ciprofibrate therapy. Atherosclerosis 1996;124(Suppl):S21-528
48. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990;86:75-79
49. Jessup W. Oxidized lipoproteins and nitric oxide. Curr Opin Lipidol 1996;7:274-280
50. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992;89:10-18
51. Morris NH, Eaton BM, Dekker G. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1996;103:4-15
52. Ishii H, Kizaki K, Horie S, Kazama M. Oxidized low density lipoprotein reduces thrombomodulin transcription in cultured human endothelial cells through degradation of the lipoprotein in lysosomes. J Biol Chem 1996;271:8458-8465
53. 2 and tumor necrosis factor-α activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promotor. J Biol Chem 1995;270:18966-18974
54. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138-1144
55. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JCP. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in preeclampsia: Does this indicate the mechanism of leucocyte activation? Br J Obstet Gynaecol 1994;101:485-487
56. Yamamoto T, Bujo H. Close encounters with apolipoprotein E receptor. Curr Opin Lipidol 1996;7:298-302
57. Hamsten A. Coagulation factors and hyperlipidaemia. Curr Opin Lipidol 1991;2:266-271
58. Arbogast BW, Leeper SC, Merrick RD, Olive KE, Taylor RN. Which plasma factors bring about disturbance of endothelial function in pre-eclampsia? Lancet 1994;343:340341
59. Wisdom SJ, Wilson R, McKillop JH, Walker J. Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol 1991;165:1701-1704
60. Hubel CA, Kozlov AV, Kagan VE, et al. Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: Implications for oxidative stress. Am J Obstet Gynecol 1886;175:692-700
61. Endresen MJ, Tosti E, Lorentzen B, Henriksen T. Sera of preeclamptic women are not cytotoxic to endothelial cells in culture. Am J Obstet Gynecol 1995;172:196-201
62. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet 1994;344: 721-724
63. 2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 1994;93:998-1004
64. Walsh SW, Wang Y, Vaughan JE. Placental production of 8-isoprostane is significantly increased in preeclampsia. J Soc Gynecol Invest 1997;4(Suppl):96A
65. 2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 1993;264:C1619-C1624
66. 2-isoprostane, 8-epiprostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/ endoperoxide receptor antagonist. Prostaglandins 1992;44:155-163